Durable Oncologic Outcomes Reported for RARP
Robotic-assisted radical prostatectomy (RARP) is associated with long-term biochemical relapse-free survival, according to a study presented at the American Urological Association 2012 annual meeting.
Robotic-assisted radical prostatectomy (RARP) is associated with long-term biochemical relapse-free survival, according to a study presented at the American Urological Association 2012 annual meeting.
WASHINGTON, D.C.—Robot-assisted radical prostatectomy (RARP) for localized prostate cancer (PCa) offers favorable intermediate- and long-term oncologic outcomes, researchers reported at the American Urological Association 2011 annual meeting.
The first long-term study looking at robot-assisted radical prostatectomy has found it is safe and has a low complication rate.
VIENNA—Robot-assisted radical prostatectomy (RARP) for localized prostate cancer (PCa) offers “highly satisfactory” five-year oncologic outcomes, according to investigators.
Robot-assisted radical prostatectomy (RARP) is comparable to conventional RP with regard to biochemical recurrence-free survival (BCRFS) in men with high-grade prostate cancer (PCa), study findings suggest.
Robot-assisted radical prostatectomy (RARP) for localized prostate cancer (PCa) confers effective five-year biochemical control of the disease, according to researchers.
Researchers have identified independent factors associated with early recovery of urinary continence after robot-assisted radical prostatectomy (RARP). These factors include lower preoperative PSA values, higher Sexual Health Inventory for Men (SHIM) score, and shorter operative time.
Clinical stage is the only preoperative variable independently associated with positive surgical margins (PSMs) following robot-assisted laparoscopic radical prostatectomy (RARP) for prostate cancer, according to researchers.
Robotic-assisted radical prostatectomy (RARP) for clinically localized prostate cancer is associated with lower rates of complications than retropubic radical prostatectomy (RRP), including infections, bladder neck contracture, and the need for blood transfusions, according to a Swedish study.
Researchers at Mayo Clinic in Phoenix have reported a promising early experience with performing extraperitoneal robot-assisted radical prostatectomy (RARP) procedures on an outpatient basis.